• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Kraken Enhances Crypto Trading with Tether Gold Listing

chest

Kraken has recently added Tether Gold to its trading menu, providing traders with enhanced options for commodity-backed assets within the crypto market.

user avatarMiguel Rodriguez

Chainlink Integrates Arbitrum Orbit to Enhance Layer 3 Messaging Security

chest

Chainlink has announced its integration with Arbitrum Orbit to enhance security in Layer 3 messaging using its Cross-Chain Interoperability Protocol.

user avatarArif Mukhtar

Aave V3 Launches on zkSync Era, Enhancing DeFi Lending

chest

Aave V3 has been launched on the zkSync Era, expanding DeFi lending capabilities within the ZK rollup environment.

user avatarLuis Flores

BNB Chain's Haber Upgrade Enhances Developer Experience

chest

The Haber upgrade on BNB Chain introduces technical improvements aimed at enhancing the developer and validator experience.

user avatarMaria Gutierrez

Coinbase Supports Render, Enhancing AI Compute Trading

chest

Coinbase's recent support for Render enhances liquidity and access for AI compute traders, increasing trading volume and market participation.

user avatarDavid Robinson

Fidelity Bitcoin ETF Sees Institutional Inflows Amid Market Volatility

chest

Fidelity's latest Bitcoin ETF inflow indicates continued institutional interest despite market fluctuations.

user avatarAndrew Smith

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.